Italian Job For K2M

In short

There’s a rule in European medical device world, which says that you can always get new technologies to market most quickly in Italy. The country has a voracious appetite for new stuff and a distributor culture that contrasts with that of northern European conservatism. It’s perhaps unsurprising then to see K2M, Inc., announcing the Italian launch of its MESA® Spinal Systems and SERENGETI® Minimally Invasive Retractor Systems.


K2M’s Italian launch marks the latest in a series of important international accomplishments for the company as it picks its way through the minefield which is the European market. Recent milestones include the European expansion of the company’s breakthrough Rail 4D™ Technology in Denmark, Germany, Holland, the United Kingdom, Switzerland, Spain, Sweden, and Ireland, as well as the introduction of its minimally invasive portfolio in Germany and the broader D-A-CH market.

The Italian launch was marked by an event at which spine leaders from across the country gathered at the Historical Rizzoli Institute to talk about the latest research in complex spine surgeries and review cases of patients treated with K2M products.

K2M’s top-loading MESA Spinal Systems feature so-called Zero-Torque Technology®, which as the name suggests applies zero torsional loads, or twisting forces, to the spine when locking the screw. Offering a variety of screw types, coupled with revolutionary instrumentation, K2M says its systems are uniquely designed to address the most difficult correction manoeuvres, while providing the surgeon the ability to one-step lock.

The SERENGETI Minimally Invasive Retractor Systems feature a flexible polymer Retractor, which provides direct visualisation and access to the screw heads to allow for simplified rod insertion. The Retractor is inserted with the screw, allowing for one-step, percutaneous placement of the implants.

Physician comments

“The innovative MESA and SERENGETI systems allow surgeons increased flexibility in their intraoperative decision-making, meeting a wide range of current unmet needs in spinal surgeries. The availability of new technologies for surgeons presents significant short and long term advantages to Italian patients,” said Stefano Boriani, MD, Director, Department of Oncologic and Degenerative Spine Surgery, Rizzoli Institute.

Company comments

“The Italian launch of MESA and SERENGETI marks another important milestone in K2M’s mission to be the global spine market leader,” stated Eric Major, K2M’s President and CEO. “We look forward to bringing K2M’s full portfolio of breakthrough products to Italy, as it is critical to our commitment to patient care around the world.”

Source: K2M, Inc.